| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2024-09-10 18:59:59 UTC |
|---|
| Updated at | 2024-09-10 19:00:00 UTC |
|---|
| NP-MRD ID | NP0334581 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Tannase |
|---|
| Description | Nalidixic Acid, also known as acide nalidixique or nalidixate, belongs to the class of organic compounds known as naphthyridine carboxylic acids and derivatives. Naphthyridine carboxylic acids and derivatives are compounds containing a naphthyridine moiety, where one of the ring atoms bears a carboxylic acid group. A monocarboxylic acid comprising 1,8-naphthyridin-4-one substituted by carboxylic acid, ethyl and methyl groups at positions 3, 1, and 7, respectively. Nalidixic Acid is a drug which is used for the treatment of urinary tract infections caused by susceptible gram-negative microorganisms, including the majority of e. Coli, enterobacter species, klebsiella species, and proteus species. Tannase was first documented in 1964 (PMID: 14107587). Nalidixic Acid is a strong basic compound (based on its pKa) (PMID: 11321869) (PMID: 12002106) (PMID: 12399485) (PMID: 12702698). |
|---|
| Structure | CCN1C=C(C(O)=O)C(=O)C2=C1N=C(C)C=C2 InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17) |
|---|
| Synonyms | | Value | Source |
|---|
| 1,4-Dihydro-1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid | ChEBI | | 1-Aethyl-7-methyl-1,8-naphthyridin-4-on-3-karbonsaeure | ChEBI | | 1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid | ChEBI | | 1-Ethyl-7-methyl-1,4-dihydro-1,8-naphthyridin-4-one-3-carboxylic acid | ChEBI | | 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid | ChEBI | | 3-Carboxy-1-ethyl-7-methyl-1,8-naphthyridin-4-one | ChEBI | | Acide nalidixique | ChEBI | | Acido nalidixico | ChEBI | | Acidum nalidixicum | ChEBI | | NA | Kegg | | NegGram | Kegg | | 1,4-Dihydro-1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate | Generator | | 1-Ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylate | Generator | | 1-Ethyl-7-methyl-1,4-dihydro-1,8-naphthyridin-4-one-3-carboxylate | Generator | | 1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylate | Generator | | Nalidixate | Generator | | Acid, nalidixic | HMDB | | Nevigramon | HMDB | | Sodium, nalidixate | HMDB | | Nalidixate sodium | HMDB | | Nalidixin | HMDB | | Sodium nalidixic acid, anhydrous | HMDB | | Anhydrous, nalidixate sodium | HMDB | | Nalidixate sodium anhydrous | HMDB | | Sodium anhydrous, nalidixate | HMDB | | Sodium nalidixic acid, monohydrate | HMDB |
|
|---|
| Chemical Formula | C12H12N2O3 |
|---|
| Average Mass | 232.2353 Da |
|---|
| Monoisotopic Mass | 232.08479 Da |
|---|
| IUPAC Name | 1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid |
|---|
| Traditional Name | nalidixic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CCN1C=C(C(O)=O)C(=O)C2=C1N=C(C)C=C2 |
|---|
| InChI Identifier | InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17) |
|---|
| InChI Key | MHWLWQUZZRMNGJ-UHFFFAOYSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as naphthyridine carboxylic acids and derivatives. Naphthyridine carboxylic acids and derivatives are compounds containing a naphthyridine moiety, where one of the ring atoms bears a carboxylic acid group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Diazanaphthalenes |
|---|
| Sub Class | Naphthyridines |
|---|
| Direct Parent | Naphthyridine carboxylic acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Naphthyridine carboxylic acid
- Pyridine carboxylic acid
- Pyridine carboxylic acid or derivatives
- Methylpyridine
- Pyridine
- Heteroaromatic compound
- Vinylogous amide
- Azacycle
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Organic oxide
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Mahmood A: Nalidixic acid is still the drug of choice for shigellosis in Pakistan. J Pak Med Assoc. 2001 Feb;51(2):101. [PubMed:11321869 ]
- Mache A: Antibiotic resistance and sero-groups of shigella among paediatric out-patients in southwest Ethiopia. East Afr Med J. 2001 Jun;78(6):296-9. doi: 10.4314/eamj.v78i6.9022. [PubMed:12002106 ]
- Kim N, Weeks DL, Shin JM, Scott DR, Young MK, Sachs G: Proteins released by Helicobacter pylori in vitro. J Bacteriol. 2002 Nov;184(22):6155-62. doi: 10.1128/JB.184.22.6155-6162.2002. [PubMed:12399485 ]
- Andersson MI, MacGowan AP: Development of the quinolones. J Antimicrob Chemother. 2003 May;51 Suppl 1:1-11. doi: 10.1093/jac/dkg212. [PubMed:12702698 ]
- NISHIURA T, YOKOYAMA S, ISHIGAMI Y: [NALIDIXIC ACID: A NEW ANTIBACTERIAL AGENT]. Hinyokika Kiyo. 1964 Jan;10:41-6. [PubMed:14107587 ]
|
|---|